Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials

Timo Vesikari; Ilse Dieussaert; Sumita Roy-Ghanta; David W Vaughn; Jan Hendrik Richardus; Johan Berglund; Tiina Korhonen; Carl-Erik Flodmark; Ann Lindstrand; Sven Arne Silfverdal; Vinod Bambure; Adrian Caplanusi

doi:10.1097/INF.0000000000000709

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials

Timo Vesikari, Ilse Dieussaert, Sumita Roy-Ghanta, David W Vaughn, Jan Hendrik Richardus, Johan Berglund, Tiina Korhonen, Carl-Erik Flodmark, Ann Lindstrand, Sven Arne Silfverdal, Vinod Bambure, Adrian Caplanusi

Research output: Contribution to journal › Article › Scientific › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	774-782
Journal	Pediatric Infectious Disease Journal
Volume	34
Issue number	7
DOIs	https://doi.org/10.1097/INF.0000000000000709
Publication status	Published - 2015
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/INF.0000000000000709

Cite this

Vesikari, T., Dieussaert, I., Roy-Ghanta, S., Vaughn, D. W., Richardus, J. H., Berglund, J., Korhonen, T., Flodmark, C.-E., Lindstrand, A., Silfverdal, S. A., Bambure, V., & Caplanusi, A. (2015). Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials. Pediatric Infectious Disease Journal, 34(7), 774-782. https://doi.org/10.1097/INF.0000000000000709

@article{b46e462214d645d68fe3c40b6e4cd4ec,

title = "Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials",

author = "Timo Vesikari and Ilse Dieussaert and Sumita Roy-Ghanta and Vaughn, {David W} and Richardus, {Jan Hendrik} and Johan Berglund and Tiina Korhonen and Carl-Erik Flodmark and Ann Lindstrand and Silfverdal, {Sven Arne} and Vinod Bambure and Adrian Caplanusi",

year = "2015",

doi = "10.1097/INF.0000000000000709",

language = "English",

volume = "34",

pages = "774--782",

journal = "Pediatric Infectious Disease Journal",

issn = "0891-3668",

publisher = "Lippincott, Williams & Wilkins",

number = "7",

}

Vesikari, T, Dieussaert, I, Roy-Ghanta, S, Vaughn, DW, Richardus, JH, Berglund, J, Korhonen, T, Flodmark, C-E, Lindstrand, A, Silfverdal, SA, Bambure, V & Caplanusi, A 2015, 'Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials', Pediatric Infectious Disease Journal, vol. 34, no. 7, pp. 774-782. https://doi.org/10.1097/INF.0000000000000709

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials. / Vesikari, Timo; Dieussaert, Ilse; Roy-Ghanta, Sumita et al.
In: Pediatric Infectious Disease Journal, Vol. 34, No. 7, 2015, p. 774-782.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials

AU - Vesikari, Timo

AU - Dieussaert, Ilse

AU - Roy-Ghanta, Sumita

AU - Vaughn, David W

AU - Richardus, Jan Hendrik

AU - Berglund, Johan

AU - Korhonen, Tiina

AU - Flodmark, Carl-Erik

AU - Lindstrand, Ann

AU - Silfverdal, Sven Arne

AU - Bambure, Vinod

AU - Caplanusi, Adrian

PY - 2015

Y1 - 2015

U2 - 10.1097/INF.0000000000000709

DO - 10.1097/INF.0000000000000709

M3 - Article

SN - 0891-3668

VL - 34

SP - 774

EP - 782

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

IS - 7

ER -

Vesikari T, Dieussaert I, Roy-Ghanta S, Vaughn DW, Richardus JH, Berglund J et al. Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials. Pediatric Infectious Disease Journal. 2015;34(7):774-782. doi: 10.1097/INF.0000000000000709